Key facts
- This page summarizes CLOVER WOLF CAPITAL - LIMITED PARTNERSHIP's Form 4 filing for PLURISTEM THERAPEUTICS INC (PLUR).
- 6 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 01 Jun 2021, 07:34.
CLOVER WOLF CAPITAL - LIMITED PARTNERSHIP - 26 May 2021 Form 4 Insider Report for PLURISTEM THERAPEUTICS INC (PLUR)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- PLUR
- Reported as of
- 26 May 2021
- Net transaction value
- -$1,314,277
- SEC form
- 4
- Accepted by SEC
- 01 Jun 2021, 07:34:17 UTC
- Prior SEC filing
- 27 May 2021
- Source filing
- View source filing
- Reporting owner signature
- Clover Wolf Capital - Limited Partnership By: Clover Wolf Ltd., its General Partner /s/ Adi Wolf, Chief Executive Officer and Managing Member
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
CLOVER WOLF CAPITAL - LIMITED PARTNERSHIP filed Form 4 for PLURISTEM THERAPEUTICS INC (PLUR) on 01 Jun 2021.
Change
- Previous filing in this sequence was filed on 27 May 2021.
- Current net transaction value: -$1,314,277.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PLUR
transaction
Common Stock
Sale
- Transaction value
- $451,400
- Shares
- -122,663
- Change %
- -3.5%
- Price
- $3.68
- Shares after
- 3,354,825
- Date
- 26 May 2021
- Ownership
- Direct
- Footnotes
- F1
PLUR
transaction
Common Stock
Sale
- Transaction value
- $81,235
- Shares
- -22,015
- Change %
- -0.66%
- Price
- $3.69
- Shares after
- 3,332,810
- Date
- 26 May 2021
- Ownership
- Direct
- Footnotes
- F2
PLUR
transaction
Common stock
Sale
- Transaction value
- $264,850
- Shares
- -71,775
- Change %
- -2.2%
- Price
- $3.69
- Shares after
- 3,261,035
- Date
- 27 May 2021
- Ownership
- Direct
- Footnotes
- F3
PLUR
transaction
Common stock
Sale
- Transaction value
- $88,966
- Shares
- -24,110
- Change %
- -0.74%
- Price
- $3.69
- Shares after
- 3,236,925
- Date
- 27 May 2021
- Ownership
- Direct
- Footnotes
- F4
PLUR
transaction
Common stock
Sale
- Transaction value
- $260,426
- Shares
- -70,007
- Change %
- -2.2%
- Price
- $3.72*
- Shares after
- 3,166,918
- Date
- 28 May 2021
- Ownership
- Direct
- Footnotes
- F5
PLUR
transaction
Common stock
Sale
- Transaction value
- $167,400
- Shares
- -45,000
- Change %
- -1.4%
- Price
- $3.72*
- Shares after
- 3,121,918
- Date
- 28 May 2021
- Ownership
- Direct
- Footnotes
- F6
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
CLOVER WOLF CAPITAL - LIMITED PARTNERSHIP is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 6 footnotes
Footnote F1
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from approximately $3.64 to $3.70 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Footnote F2
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from approximately $3.63 to $3.73 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Footnote F3
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from approximately $3.66 to $3.72 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Footnote F4
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from approximately $3.68 to $3.69 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Footnote F5
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from approximately $3.72 to $3.75 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Footnote F6
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from approximately $3.70 to $3.74 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.